[{"AccountsPayableCurrent_0_Q3_USD":2024000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1_Q3_USD":57000.0,"OtherAssetsNoncurrent_0_Q3_USD":147000.0,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":97000.0,"OperatingLeaseExpense_3_Q3_USD":500000.0,"OperatingLeaseExpense_1_Q3_USD":200000.0,"OperatingIncomeLoss_3_Q3_USD":-33607000.0,"OperatingIncomeLoss_1_Q3_USD":-18375000.0,"OperatingExpenses_3_Q3_USD":52550000.0,"OperatingExpenses_1_Q3_USD":18375000.0,"NetIncomeLossAttributableToNoncontrollingInterest_3_Q3_USD":-223000.0,"NetIncomeLossAttributableToNoncontrollingInterest_1_Q3_USD":-909000.0,"NetIncomeLoss_3_Q3_USD":-33056000.0,"NetIncomeLoss_1_Q3_USD":-17350000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-28262000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-317913000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":266082000.0,"MinorityInterest_0_Q3_USD":2088000.0,"LongTermInvestments_0_Q3_USD":124330000.0,"LiabilitiesCurrent_0_Q3_USD":7863000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":453404000.0,"Liabilities_0_Q3_USD":7930000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_3_Q3_USD":-56000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q3_USD":150000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q3_USD":57000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":-12000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":579000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q3_USD":4557000.0,"StockholdersEquityNoteStockSplitConversionRatio1_3_Q3_pure":1.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q3_USD":445474000.0,"StockholdersEquity_0_Q3_USD":443386000.0,"ShortTermInvestments_0_Q3_USD":232939000.0,"ShareBasedCompensation_3_Q3_USD":12230000.0,"RoyaltyExpense_3_Q3_USD":0.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":18943000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-126395000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":36873000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":12680000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":89000.0,"ProfitLoss_3_Q3_USD":-33279000.0,"ProfitLoss_1_Q3_USD":-18259000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":579000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_3_Q3_USD":130638000.0,"ProceedsFromPaymentsToMinorityShareholders_3_Q3_USD":923000.0,"ProceedsFromIssuanceInitialPublicOffering_3_Q3_USD":267268000.0,"PrepaidExpenseCurrent_0_Q3_USD":7794000.0,"PaymentsToAcquireMarketableSecurities_3_Q3_USD":448551000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":-2000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q3_USD":618000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q3_USD":313000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q3_USD":608000.0,"CommonStockSharesIssued_0_Q3_shares":43660909.0,"CommonStockSharesAuthorized_0_Q3_shares":150000000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"CommitmentsAndContingencies_0_Q3_USD":null,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_3_Q3_USD":-80093000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q3_USD":88105000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":88105000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q3_USD":357269000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q3_USD":357327000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q3_USD":80000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q3_USD":22000.0,"AssetsCurrent_0_Q3_USD":328838000.0,"Assets_0_Q3_USD":453404000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":7334314.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":12230000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":4557000.0,"AdditionalPaidInCapitalCommonStock_0_Q3_USD":569835000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":-58000.0,"AccruedProfessionalFeesCurrent_0_Q3_USD":755000.0,"AccruedLiabilitiesCurrent_0_Q3_USD":5839000.0,"AccruedBonusesCurrent_0_Q3_USD":1764000.0,"CommonStockSharesOutstanding_0_Q3_shares":43660909.0,"CommonStockValue_0_Q3_USD":4000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-17293000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-33112000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q3_USD":1689000.0,"InvestmentIncomeInterest_3_Q3_USD":340000.0,"InvestmentIncomeInterest_1_Q3_USD":118000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":5104000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":-5980000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":0.0,"IncomeTaxExpenseBenefit_1_Q3_USD":0.0,"IncomeLossAttributableToNoncontrollingInterest_3_Q3_USD":-200000.0,"IncomeLossAttributableToNoncontrollingInterest_1_Q3_USD":-900000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":15677000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":43254230.0,"GeneralAndAdministrativeExpense_1_Q3_USD":5695000.0,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-0.4,"DividendsPayableCurrentAndNoncurrent_0_Q3_USD":0.0,"DepreciationDepletionAndAmortization_3_Q3_USD":41000.0,"DeferredTaxAssetsValuationAllowance_0_Q3_USD":0.0,"DeferredRentCreditNoncurrent_0_Q3_USD":67000.0,"DeferredOfferingCosts_0_Q3_USD":2700000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_3_Q3_USD":-33335000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1_Q3_USD":-18202000.0,"ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_3_Q3_USD":-223000.0,"ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_1_Q3_USD":-909000.0,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-0.76,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":43438861.0,"Ticker":"CGEM","CIK":"1789972","name":"CULLINAN ONCOLOGY, INC.","OfficialName":"Cullinan Oncology Inc. Common Stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"494263432.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20211109"}]